Testing effectiveness (Phase 2)Study completedNCT00251537What this trial is testingA Pilot Study of LTB4 in HIV-1 Infected AdultsWho this might be right forHIV Infections LTB4 Sweden AB 40
Early research (Phase 1)Study completedNCT00393276What this trial is testingDetermining Responses to Two Different Vaccines in HIV and HCV Infected IndividualsWho this might be right forHIV InfectionsHepatitis C National Institute of Allergy and Infectious Diseases (NIAID) 29
Not applicableStudy completedNCT01226368What this trial is testingEpidemiology of Papillomavirus Infection (HPV) on Infected Women by Human Immunodeficience Virus (HIV) in West Indies and French Guiana.Who this might be right for1- Women2- HIV Infection3- Followed in West Indies and French Guiana for His Infection+1 more University Hospital Center of Martinique 455
Not applicableStudy completedNCT00000955What this trial is testingTwo-Stage Tuberculin (PPD) Skin Testing in Individuals With Human Immunodeficiency Virus (HIV) InfectionWho this might be right forHIV InfectionsTuberculosis National Institute of Allergy and Infectious Diseases (NIAID) 864
Not applicableStudy completedNCT03408678What this trial is testingDeterminants of Type 2 Diabetes Risk in Middle-aged Black South African Men and WomenWho this might be right forDiabetes Mellitus, Type 2Insulin ResistanceMenopause+1 more University of Witwatersrand, South Africa 1,025
Early research (Phase 1)Study completedNCT01503255What this trial is testingA Stage 2 Cognitive-behavioral Trial: Reduce Alcohol First in Kenya InterventionWho this might be right forHazardous DrinkingBinge DrinkingHIV-infected Brown University 614
Not applicableStudy completedNCT00004855What this trial is testingEffects of Two Anti-HIV Drug Combinations on the Immune Systems of HIV-Infected Patients Who Have Never Received Anti-HIV DrugsWho this might be right forHIV Infections National Institute of Allergy and Infectious Diseases (NIAID) 55
Early research (Phase 1)Study completedNCT00001043What this trial is testingA Phase I, Multicenter, Randomized Trial to Evaluate the Safety and Immunogenicity of Vaccinia-Derived MN HIV-1 Recombinant Envelope Glycoprotein (rgp160) of Human Immunodeficiency Virus at Two Different Vaccination SchedulesWho this might be right forHIV InfectionsHIV Seronegativity National Institute of Allergy and Infectious Diseases (NIAID) 20
Early research (Phase 1)UnknownNCT00013572What this trial is testingHIV Candidate Vaccine, ALVAC-HIV-1, Administration in HIV-Negative AdultsWho this might be right forHIV InfectionsHIV Seronegativity Walter Reed Army Institute of Research (WRAIR) 36
Not applicableStudy completedNCT00002035What this trial is testingDouble-Blind Comparison of the Efficacy of Continued Zidovudine Versus 2',3'-Dideoxyinosine (ddI) (BMY-40900) for the Treatment of Patients With AIDS or AIDS-Related Complex and Increasing Symptomatology Despite Treatment With ZidovudineWho this might be right forHIV Infections Bristol-Myers Squibb 300
Testing effectiveness (Phase 2)Study completedNCT00352911What this trial is testingAntiviral Activity and Safety of Mifepristone at 2 Doses in HIV-1 Infected SubjectsWho this might be right forHIV Infections VGX Pharmaceuticals, LLC 19
Early research (Phase 1)Looking for participantsNCT05334004What this trial is testingLopinavir/Ritonavir in PLWH With High-Grade AINWho this might be right forHigh-Grade Anal Intraepithelial Neoplasia University of Wisconsin, Madison 21
Large-scale testing (Phase 3)Study completedNCT00002447What this trial is testingCompare Two Anti-HIV Drug CombinationsWho this might be right forHIV Infections Hoffmann-La Roche 146
Not applicableStudy completedNCT00002168What this trial is testingA Comparison of Two Anti-HIV Triple-Drug Combinations in HIV-Infected PatientsWho this might be right forHIV Infections Bristol-Myers Squibb 200
Large-scale testing (Phase 3)Study completedNCT00130247What this trial is testingTuberculosis Treatment Shortening TrialWho this might be right forTuberculosis National Institute of Allergy and Infectious Diseases (NIAID) 394
Early research (Phase 1)Enrolling By InvitationNCT05983874What this trial is testingEvaluate the Safety and Immunogenicity of 2 Doses of 100µg BG505 SOSIP.664 gp140 Vaccine, Adjuvanted, Given to a Population of Adults Who Have Received 3 Doses of 300µg BG505 SOSIP.GT1.1 gp140 Vaccine, AdjuvantedWho this might be right forHiv International AIDS Vaccine Initiative 8
Not applicableStudy completedNCT00002275What this trial is testingA Comparison of Two Types of Injected Nutritional Supplements in Patients With AIDS and Pneumocystis Carinii Pneumonia (PCP)Who this might be right forHIV Infections Abbott
Testing effectiveness (Phase 2)Study completedNCT01155037What this trial is testingSafety of and Immunogenicity to an H1N1 Influenza Vaccine in HIV-infected AdultsWho this might be right forHIV Infection Oswaldo Cruz Foundation 450
Post-approval studies (Phase 4)Study completedNCT00344461What this trial is testingA Two Year Study of the Clinical Efficacy of the Combination of Emtricitabine, Tenofovir, and NevirapineWho this might be right forHIV University of Maryland, Baltimore 54
Not applicableUnknownNCT04044586What this trial is testingHIV and HCV Infections in 2 Communes From the Battambang Province, Cambodia: Prevalence Rates, Viral Strains, and Unsafe Injection Practices (12352 ANRS ROK INVEST)Who this might be right forHIV SeropositivityHCV Infection ANRS, Emerging Infectious Diseases 1,098